Specific PLK1/PLK1 knockdown on both protein and mRNA level is achieved by short interfering Ribonucleic Neutrals (siRNNs) as pro-drugs which can be cleaved intracellularly into short interfering ribonucleic acids (siRNAs) as demonstrated in leukemia [251]. This evidence concerns the gene PLK1 and leukemia.